Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Start Upstream, Leverage the Team—Deprescribing in Patients With Dementia
AR Green - JAMA Internal Medicine, 2024 - jamanetwork.com
People with dementia face a higher risk of polypharmacy and potentially inappropriate
medication use compared to those without cognitive impairment. 1 Deprescribing has been …
medication use compared to those without cognitive impairment. 1 Deprescribing has been …
Exploring the association between intention and action in deprescribing
HB Mehta, VK Sekhon, E Reeve… - Journal of the …, 2024 - Wiley Online Library
RESULTS Of the 1938 older adults who completed the PATD, 694 used≥ 1 PIM in the 6
months prior. The five most common PIM at baseline were opioids (315, 16%), proton pump …
months prior. The five most common PIM at baseline were opioids (315, 16%), proton pump …
An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot Study
NM Barnett, SE Vordenberg, HM Kim, M Turnwald… - Drugs & Aging, 2025 - Springer
Background Central nervous system (CNS)-active polypharmacy (defined as concurrent
exposure to three or more antidepressant, antipsychotic, antiseizure, benzodiazepine …
exposure to three or more antidepressant, antipsychotic, antiseizure, benzodiazepine …